• Facebook
  • linked in
  • Instagram
  • YouTube

A TREATMENT

DEVICE FAR SUPERIOR

putting cancer in focus

The Next Generation of LINAC-MR

AM21_LinkedIn_1200x627.jpg

Join us
in booth #257

Schedule a meeting with an Executive.

PATIENT COMFORT

+
NO ELECTRON RETURN EFFECT

MR imaging is well-known for its exquisite soft-tissue contrast. Though state-of-the-art linear accelerators (LINAC) have Cone Beam CT (CBCT) image guidance, they also have challenges: low contrast and CT images can’t be captured concurrently with the beam delivery. 

 

The advanced Aurora-RT™* is different — it smartly combines high-quality MR images with a 6 MV linear accelerator. Our machine provides excellent images before treatment for accurate patient alignment  — and its real-time MR imaging during beam delivery allows prior gating of tumor-tracking features. These designs make the Aurora-RT perfectly suited for adaptive radiotherapy.

*The technology for Aurora-RT is in development and is not yet available for sale for clinical use.

 

AURORA-RT

PATIENT

COMFORT

We created pioneering technology with patient safety and comfort in mind.

CLINICIAN BENEFITS

We provide a better experience for clinical providers and facilities.

patient

safety

Patient safety and well-being is our #1 focus.

ADVANCED TECH & precision 

Our machine’s powerful advanced capabilities provide precision and accuracy.

Built

Smarter

Aurora-RT's innovative machine is built unlike any other – making maintenance a breeze while appearing less intimidating for patients. 

Software

compatibility

We are an open source for treatment planning systems.

better for our planet

Our use of helium gas eliminates the need for liquid helium, which is beneficial for Mother Earth. 

wider variety 

of treatments

Smart design and the table's modular capabilities can do more for patients.

features of Aurora–rt

Open-Concept

Untitled_Artwork.png

Real-Time Imaging

"Having led the research and development of the Bi-planar linac-MR since its inception, it is an incredible thrill to commercialize and witness its clinical advantages in use."

Gino Fallone